Search

Search Results

• 

  Vitiligo: What’s old, what’s new

  Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli

  15-09-2021

  https://doi.org/10.4081/dr.2021.9142

  2652

  PDF: 1145

  HTML: 207

• The efficacy of apremilast in pemphigus: a systematic review of case reports

  Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri

  07-05-2025

  https://doi.org/10.4081/dr.2025.10245

  897

  PDF: 400

  SUPPLEMENTARY MATERIAL: 34

  HTML: 8

• The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

  Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi

  01-07-2025

  https://doi.org/10.4081/dr.2025.10112

  767

  PDF: 555

  HTML: 20
• 

  Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

  Louise Rottboell, Sarah de Foenss, Kenneth Thomsen, Helle Christiansen, Stine M. Andersen, Thomas N. Dam, Cecilia Rosada, Karin Stenderup

  17-12-2015

  https://doi.org/10.4081/dr.2015.6246

  3154

  PDF: 945

  HTML: 753
• 

  Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study

  Tannaz Dehpouri, Ghasem Rahmatpour Rokni, Nematollah Ahangar Narenjbon, Mohamad Goldust, Paul S. Yamauchi, Uwe Wollina, Torello Lotti, Leon Kircik, Vito Giuseppe Di Lernia, Sidharth Sonthalia, Aleksandra Vojvodic, Jacek Szepietowski, Philippe Bahadoran, Enzo Errichetti, Carmen Cantisani, Laura Atzori, Elham Rezaee, Zekayi Kutlubay, Burhan Engin, Steven Nisticò, Giovanni Damiani, Rosalynn R.Z. Conic, Andy Goren, Leo Čabrijan, Georgi Tchernev

  09-05-2019

  https://doi.org/10.4081/dr.2019.7965

  2199

  PDF: 951

  HTML: 920

• Calcipotriol as a daylight photodynamic therapy enhancer: a case-control study

  Benedetta Sonego, Enrico Zelin, Serena Bonin, Tommaso Pozzebon, Giulia Bazzacco, Andrea Corio, Marina Agozzino, Dante Raffaele Caro Caposiena, Iris Zalaudek, Nicola di Meo

  01-10-2024

  https://doi.org/10.4081/dr.2024.10077

  1009

  PDF: 504

  HTML: 90

• Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review

  Sahar Alruhaimi, Fatimah Alowirdi, Waleed Al-Ajroush

  05-03-2025

  https://doi.org/10.4081/dr.2025.10239

  541

  PDF: 327

  HTML: 14

• Efficacy of a topical polyphenol-based formulation in palmoplantar psoriasis: an observational study

  Simone Amato, Annunziata Dattola, Luigi Bennardo, Martina Tolone, Steven Paul Nisticò

  08-07-2025

  https://doi.org/10.4081/dr.2025.10333

  385

  PDF: 240

  HTML: 0
• 

  Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

  Federica Mola, Alberico Motolese

  e40

  03-10-2011

  https://doi.org/10.4081/dr.2011.e40

  1259

  PDF: 595

  HTML: 1071
• 

  Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

  Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

  21-11-2022

  https://doi.org/10.4081/dr.2022.9447

  1306

  PDF: 405

  HTML: 45
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2393

  PDF: 1409

  HTML: 106
• 

  Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

  Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

  29-07-2021

  https://doi.org/10.4081/dr.2021.8797

  3060

  PDF: 647

  HTML: 10
• 

  Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

  Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

  23-11-2022

  https://doi.org/10.4081/dr.2022.9476

  1359

  PDF: 491

  HTML: 26
• 

  Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

  Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

  01-10-2018

  https://doi.org/10.4081/dr.2018.7859

  1980

  PDF: 1055

  HTML: 63
• 

  Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients, and vaccine-associated dermatoses: a clinical atlas and a large original study of two general COVID-19 centers from Iran

  Afsaneh Sadeghzadeh-Bazargan, Azadeh Goodarzi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9473

  979

  PDF: 462

  SUPPLEMENTARY FILE: 144

  HTML: 22
• 

  Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

  Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

  17-03-2022

  https://doi.org/10.4081/dr.2022.9282

  1162

  PDF: 825

  HTML: 41
• 

  Late reaction to ustekinumab infusion

  Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

  e2

  09-09-2013

  https://doi.org/10.4081/dr.2013.e2

  3964

  PDF: 668

  HTML: 263
• 

  Exacerbation of generalized plaque psoriasis after tuberculin test

  Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni

  28-07-2021

  https://doi.org/10.4081/dr.2021.9019

  3189

  PDF: 503

  HTML: 227

• Refractory pityriasis rubra pilaris treated with abrocitinib

  Filip Rob

  09-01-2025

  https://doi.org/10.4081/dr.2025.10105

  406

  PDF: 273

  HTML: 11
• 

  Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

  Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

  11-10-2017

  https://doi.org/10.4081/dr.2017.7079

  1377

  PDF: 661

  HTML: 142

• Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

  Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

  19-06-2023

  https://doi.org/10.4081/dr.2023.9755

  851

  PDF: 415

  HTML: 17

• Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

  Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

  01-07-2025

  https://doi.org/10.4081/dr.2025.10315

  536

  PDF: 262

  HTML: 13
• 

  A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

  Line Raaby, Kristian Otkjær, Maria Luise Salvskov-Iversen, Claus Johansen, Lars Iversen

  e14

  14-10-2010

  https://doi.org/10.4081/dr.2010.e14

  4106

  PDF: 840

  HTML: 322
• 

  Bacterial colonization of psoriasis plaques. Is it relevant?

  Eva Marcus, Diana Demmler, Andreas Rudolph, Matthias Fischer

  e14

  05-08-2011

  https://doi.org/10.4081/dr.2011.e14

  1698

  PDF: 744

  HTML: 626

• Ultrasound monitoring of hidradenitis suppurativa fistulas in treatment with adalimumab

  Raffaele Dante Caposiena Caro, Giulia Bazzacco, Enrico Zelin, Vanessa Mazzoletti, Nicola Di Meo, Iris Zalaudek

  11-04-2025

  https://doi.org/10.4081/dr.2025.10124

  540

  PDF: 374

  HTML: 2